Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation р.T632I

by Kristina V. Orlova, Grigory A. Yanus, Svetlana N. Aleksakhina, Aigul R. Venina, Aglaya G. Iyevleva, Lev V. Demidov, Evgeny N. Imyanitov
Published 2019-01-01

Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation

by Fedor V. Moiseyenko, Vitaliy V. Egorenkov, Mikhail M. Kramchaninov, Elizaveta V. Artemieva, Svetlana N. Aleksakhina, Maxim M. Holmatov, Vladimir M. Moiseyenko, Evgeny N. Imyanitov
Published 2019-05-01

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine

by Tatiana N. Sokolova, Valeriy V. Breder, Irina S. Shumskaya, Evgeny N. Suspitsin, Svetlana N. Aleksakhina, Grigoriy A. Yanus, Vladislav I. Tiurin, Alexandr O. Ivantsov, Barbara Vona, Grigoriy A. Raskin, Sergey V. Gamajunov, Evgeny N. Imyanitov
Published 2021-01-01

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study

by Sergey V. Orlov, Aglaya G. Iyevleva, Elena A. Filippova, Alexandra M. Lozhkina, Svetlana V. Odintsova, Tatiana N. Sokolova, Natalia V. Mitiushkina, Vladislav I. Tiurin, Elena V. Preobrazhenskaya, Alexandr A. Romanko, Alexandr S. Martianov, Alexandr O. Ivantsov, Svetlana N. Aleksakhina, Alexandr V. Togo, Evgeny N. Imyanitov
Published 2021-08-01